SwischukLE, JohnSD.Immature lung problems: can our nomenclature be more specific?Am J Roentgenol1996; 166:917–918.
2.
Report of the National Neonatal Perinatal Database. National Neonatology Forum, India, 2002-2003.
3.
RodriguezRJ, MartinRJ, FanaroffAA.Respiratory distress syndrome and its management. In: Neonatal-Perinatal Medicine -Diseases of the fetus and infant. Eds: MartinRJ, FanaroffAA, WalshMC. 8th ed. Mosby Elsevier St. Louis2006:1097–1107.
4.
RegevRH, ReichmanB.Prematurity and intrauterine growth retardation -double jeopardy?Clin Perinatol2001;31:453–473.
RobertsD, DalzielS.Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev.2006;3:CD004454.
CostaS, ZeccaE, De LucaD, De CarolisMP, RomagnoliC.Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants. Eur J Obstet Gynecol Reprod Biol2007;131:154–157.
10.
SenS, ReghuA, FergusonSD.Efficacy of a single dose of antenatal steroid in surfactant-treated babies under 31 weeks' gestation. J Matern Fetal Neonatal Med.2002;12:298–303.
11.
HaasDM, McCulloughW, McNamaraMF, OlsenC.The first 48 hours: Comparing 12-hour and 24-hour betamethasone dosing when preterm deliveries occur rapidly. J Matern Fetal Neonatal Med.2006; 19:365–369.
12.
VidaeffAC, MastrobattistaJM.Controversies in the use of antenatal steroids for fetal maturation. Sem Perinatol2001;25:385–396.
13.
BanksBA, CnaanA, MorganMA, . Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol1999;181:709–717
14.
GuinnDA, AtkinsonMW, SullivanL, LeeM, MacGregorS. Single Vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA20013;286: 1581–1587.
15.
SandeshKiran PS, DuttaSourabh, NarangAnil, BhansaliAnil, MalhiPrahbhjot. Multiple courses of antenatal steroids Indian J Pediatr2007;74:463–469.
16.
VidaeffAC, DoyleNM, GilstrapLC.Antenatal corticosteroids for fetal maturation in women at risk for preterm delivery. Clin Perinatol2003;30:825–840.
17.
LundstromKE, PrydsO, GreisenG.Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Arch Dis Child Fetal Neonatal Ed.1995;73:F81–86
18.
HarlingAE, BeresfordMW, VinceGS, BatesM, YoxallCW.Does the use of 50% oxygen at birth in preterm infants reduce lung injury?Arch Dis Child Fetal Neonatal Ed.2005;90:F401–405.
19.
SchwartzRM, LubyAM, ScanlonJW, KelloggRJ.Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med1994;330:1476–1480.
20.
SollRF, BlancoF.Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev2001;2:CD000144.
21.
MoyaFR, GadzinowskiJ, BancalariE, . A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics2005;115:1018–1029.
22.
HallidayHL.History of surfactant from 1980. Biol Neonate2005;87:317–322
23.
BeenJV, ZimmermannU.What's new in surfactant?: A clinical view on recent developments in neonatology and paediatrics. Eur J Pediatr.2007 May 22; (Epub ahead of print)
SollRF, MorleyCJ.Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev.2001;2:CD000510
26.
YostCC, SollRF.Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev.2000; 2:CD001456
27.
SweetD, BevilacquaG, CarnielliV, GreisenG, PlavkaR et al European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med2007;35:175–186.
28.
FioriHH, FritscherCC, FioriRM.Selective surfactant prophylaxis in preterm infants born at < 31 weeks' gestation using the stable microbubble test in gastric aspirates. J Perinat Med.2006;34:66–70.
BroadbentR, FokTF, DolovichM, WattsJ, CoatesG, BowenB, KirpalaniH.Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits. Arch Dis Child Fetal Neonatal Ed.1995;72:F84–89.
31.
SubramaniamP, Henderson-SmartDJ, DavisPG.Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev.2005;3:CD001243.
32.
HoJJ, Henderson-SmartDJ, DavisPG.Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev.2002; 2: CD002975.
33.
Te PasAB, LoprioreE, EngbersMJ, WaltherFJ.Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study. PLoS ONE.2007;2:e192.
34.
BohlinK, GudmundsdottirT, Katz-SalamonM, JonssonB, BlennowM.Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol2007;27:422–427.
35.
DavisPG, Henderson-SmartDJ.Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev.2003;2:CD000143.
36.
StefanescuBM, MurphyWP, HansellBJ, . A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants. Pediatrics2003;112:1031–1038.
37.
KugelmanA, FeferkornI, RiskinA, ChistyakovI, KaufmanB, . Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized controlled prospective study. J Pediatr2007;150:521–526.
38.
SantinR, BrodskyN, BhandariV.A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants > or = 28 weeks with respiratory distress syndrome (RDS). J Perinatol2004,24:487–493.
39.
AmbalavananN, CarloWA.Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol.2006;30:192–199.
40.
LloydJ, AskieL, SmithJ, . Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database Syst Rev.2003;2:CD003482.
41.
MarianiG, CifuentesJ, CarloWA.Randomized trial of permissive hypercapnia in preterm infants. Pediatrics.1999;104:1082–1088.
42.
WoodgatePG, DaviesMW.Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. Cochrane Database Syst Rev.2001;2:CD002061.
43.
GreenoughA, MilnerAD, DimitriouG.Synchronized mechanical ventilation for respiratory support in newborn. Cochrane Database Syst Rev.2004; 4:CD000456.
44.
SarkarS.DonnSM.In support of pressure support. Clin Perinatol2007;34:117–128.
45.
SinghJ, SinhaSK, ClarkeP, ByrneS, DonnSM.Mechanical ventilation of very low birth weight infants: is volume or pressure a better target variable?J Pediatr.2006;149:308–313.
46.
Henderson-SmartDJ, BhutaT, CoolsF, . Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev2003;4:CD000104.
47.
JoshiVH, BhutaT.Rescue high frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev.2006; 1:CD000437.
48.
KonduriGG.New approaches for PPHN. Clin Perinatol2004;31:591–611.
49.
LindwallR, BlennowM, SvenssonM, JonssonB, Berggren-BoströmE. A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome. Intensive Care Med.2005;31:959–964.
50.
SinnJK, WardMC, Henderson-SmartDJ.Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health.2002,38:597–600.